Publication: Pharma's Almanac
Abstract
In this Pharma’s Almanac article, Karen Rowland Yeo, Ph.D., emphasizes the role of diversity and inclusivity in clinical research in tackling global health inequities. Certara uses innovative in silico modeling approaches to optimize drug dosing for underrepresented populations, such as pregnant and lactating women.
Published: 2025 年 6 月 17 日
基于虚拟人群预测临床结果
Our consultants have a proven track record in using our PBPK modeling technology for critical applications such as first-in-human (FIH) dose predictions, drug-drug interactions (DDIs), dosing for specific populations, and virtual bioequivalence.
